Debut Plus

₹129.79

▲ +5.85 +4.72%

As of 23 Oct 2026 · delayed

BSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-09-02

Asston Pharmaceuticals Limited (544445)

Volume: 1,19,000Avg Vol 1W: 77,800Avg Vol 1M: 26,40952W Range:₹60₹130.13
BSE www.asstonpharmaceuticals.com AI Report
Key Ratios
Checked 2h ago
Market Cap—
Current Price₹129.79
Previous Close₹123.94
High / Low (52w)₹130.13 / ₹60
Volume1,19,000
Avg Vol (1W)77,800
Avg Vol (1M)26,409
Stock P/E—
Book Value—
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B—
Debt / Equity0.25
50 DMA₹100.73
200 DMA₹84.9
Day change+4.72%
SurveillanceESM · ESM 1
Price Chart
₹129.79▲ 47.66% · 1Y
₹130₹623.9L
2025-10-27
2026-10-23

20-day avg volume: 28K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 23% YoY.
Profit & Loss (Annual)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹11 Cr₹7 Cr₹16 Cr₹26 Cr₹32 Cr
EBITDA₹1 Cr₹2 Cr₹3 Cr₹6 Cr₹5 Cr
Net Profit₹0 Cr₹1 Cr₹1 Cr₹4 Cr₹4 Cr
EPS11.621.892.376.144.92
Balance Sheet
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹9 Cr₹14 Cr₹20 Cr₹28 Cr₹52 Cr
Total Liabilities₹9 Cr₹12 Cr₹14 Cr₹17 Cr₹13 Cr
Equity₹1 Cr₹2 Cr₹6 Cr₹11 Cr₹39 Cr
Total Debt—————
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-1 Cr₹0 Cr₹-4 Cr₹0 Cr₹-8 Cr
Investing₹0 Cr₹-1 Cr₹0 Cr₹1 Cr₹-10 Cr
Financing₹1 Cr₹1 Cr₹4 Cr₹-1 Cr₹21 Cr
Free Cash Flow₹-1 Cr₹0 Cr₹-4 Cr₹0 Cr₹-8 Cr
Shareholding
Promoter 39.48% Institutions 0% Public 60.52%
Efficiency & Working Capital
ROCE—
Interest Coverage8.3
Dividend Payout—
Debtor Days524 d
Inventory Days11 d
Payable Days83 d
Cash Conversion Cycle453 d
Working Capital Days535 d
Shareholding Details

As of 2026-09-30

Promoter39.5%
FII0%
DII0%
Institutions0%
Public60.5%
Promoter Pledge0%
No. of Shareholders675
Shareholding Pattern

Quarterly — figures in %. Latest 6 quarters.

PeriodJan 2025Jun 2025Jul 2025Sept 2025Mar 2026Sept 2026
Promoters69.1%50.7%50.7%50.7%50.7%39.5%
FIIs0%9.7%9.7%6%1.9%0%
DIIs0%4.1%4.1%0%0%0%
Public30.9%35.6%35.6%43.3%47.4%60.5%
Promoter Pledge0%0%0%0%0%0%
No. of Shareholders104662662751687675
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Ashish Narayan SakalkarShareholding of Promoter and Promoter Group17%18,52,856
Saili Jayaram MoreShareholding of Promoter and Promoter Group17%18,52,856
Vijay RatheePublic Shareholding12.1%13,17,391
Vijaylaxmi Infra Projects Private LimitedPublic Shareholding7.2%7,82,608
Prakruti R PaliPublic Shareholding7.1%7,70,000
Sachin Chandrakant BadakhShareholding of Promoter and Promoter Group5.6%6,06,768
Mahesh Vishnupant MulayPublic Shareholding2.4%2,58,056
Kuldip Singh RatheePublic Shareholding1.8%2,00,000
Snehlata Manoj KathotiaPublic Shareholding1.4%1,56,000
Vrushali Yogesh SupekarPublic Shareholding1.1%1,24,466
Board of Directors
NameDesignationYear
Ashish Narayan SakalkarManaging Director2025
Saili Jayaram MoreWhole Time Director & CEO2025
Sachin Chandrakant BadakhNon Executive Director2025
Rishabh Kumar JainIndependent Non Exe. Director2025
Vijaya ShahpurkarIndependent Non Exe. Director2025
Vandana MishraCompany Sec. & Compli. Officer2025
Yashvardhan TupeAdditional Director2025
Sandip SharmaAdditional Director2025
Segments — Geography
RegionRevenueShare
Export₹24 Cr94.8%
Domestic₹1 Cr5.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹101199
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025010304
2025000202
2025010001
Company Information
Incorporated2019
AuditorDoshi Doshi & Co/Panchal S K & Associates
Investor Email[email protected]
🌐 www.asstonpharmaceuticals.com ↗

📍 4th Flr Office No.A-431 Balaji, Bhavan Plot No.42A Sec-11 CBD, Mumbai, Maharashtra, 400614

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Marc Loire Fashions LimitedCryogenic Ogs LimitedMeta Infotech LimitedChemkart India LimitedTravel Food ServicesGlen Industries LimitedAdvent Hotels InternationalSmartworks Coworking SpacesAnthem BiosciencesChembond Chemicals LimitedMonika Alcobev LimitedSwastika Castal LimitedAll “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search